CTSV
Basic information
Region (hg38): 9:97029677-97156556
Previous symbols: [ "CTSL2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CTSV gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 11 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 11 | 2 | 1 |
Variants in CTSV
This is a list of pathogenic ClinVar variants found in the CTSV region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-97032996-T-C | not specified | Likely benign (Aug 16, 2022) | ||
9-97035544-G-C | not specified | Uncertain significance (Jan 07, 2022) | ||
9-97035594-C-A | not specified | Uncertain significance (Feb 17, 2024) | ||
9-97035594-C-T | not specified | Uncertain significance (Jan 10, 2023) | ||
9-97035596-A-G | not specified | Uncertain significance (Apr 25, 2023) | ||
9-97035627-G-T | not specified | Uncertain significance (Aug 30, 2021) | ||
9-97035654-T-C | not specified | Uncertain significance (Apr 28, 2023) | ||
9-97036543-A-C | not specified | Uncertain significance (Jan 27, 2022) | ||
9-97036607-A-G | Benign (Jun 21, 2018) | |||
9-97036617-T-C | not specified | Uncertain significance (Dec 05, 2022) | ||
9-97036632-C-T | not specified | Likely benign (Feb 27, 2023) | ||
9-97036653-T-C | not specified | Uncertain significance (Jul 25, 2023) | ||
9-97036701-T-G | not specified | Uncertain significance (Apr 15, 2024) | ||
9-97037322-G-A | not specified | Uncertain significance (Apr 12, 2024) | ||
9-97037329-G-T | not specified | Uncertain significance (Mar 25, 2024) | ||
9-97037340-C-G | not specified | Uncertain significance (Jul 09, 2021) | ||
9-97037347-T-C | not specified | Uncertain significance (Sep 14, 2023) | ||
9-97037614-T-A | not specified | Uncertain significance (Apr 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CTSV | protein_coding | protein_coding | ENST00000259470 | 7 | 6986 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.30e-7 | 0.483 | 125689 | 0 | 59 | 125748 | 0.000235 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.289 | 177 | 188 | 0.941 | 0.0000103 | 2218 |
Missense in Polyphen | 48 | 69.073 | 0.69492 | 867 | ||
Synonymous | 0.0908 | 71 | 72.0 | 0.986 | 0.00000450 | 602 |
Loss of Function | 0.833 | 12 | 15.5 | 0.772 | 7.24e-7 | 187 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000782 | 0.000770 |
Ashkenazi Jewish | 0.000595 | 0.000595 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.0000970 | 0.0000924 |
European (Non-Finnish) | 0.000278 | 0.000273 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.00 | 0.00 |
Other | 0.000342 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Cysteine protease. May have an important role in corneal physiology. {ECO:0000269|PubMed:10029531, ECO:0000269|PubMed:9727401}.;
- Pathway
- Lysosome - Homo sapiens (human);Apoptosis - Homo sapiens (human);Endochondral Ossification;Assembly of collagen fibrils and other multimeric structures;Gene expression (Transcription);Generic Transcription Pathway;Trafficking and processing of endosomal TLR;Toll-Like Receptors Cascades;RNA Polymerase II Transcription;Collagen formation;Extracellular matrix organization;MHC class II antigen presentation;Innate Immune System;Immune System;Adaptive Immune System;Endosomal/Vacuolar pathway;Antigen processing-Cross presentation;Class I MHC mediated antigen processing & presentation;Activation of Matrix Metalloproteinases;Degradation of the extracellular matrix;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes;Transcriptional regulation by RUNX1
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 29.16
Haploinsufficiency Scores
- pHI
- 0.604
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.506
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ctsl
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; muscle phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; embryo phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype;
Gene ontology
- Biological process
- spermatogenesis;cellular response to starvation;response to glucose;multicellular organism aging;antigen processing and presentation of exogenous peptide antigen via MHC class II;nerve development;extracellular matrix disassembly;response to gonadotropin;regulation of keratinocyte differentiation;decidualization;autophagic cell death;response to glucocorticoid;proteolysis involved in cellular protein catabolic process;Sertoli cell differentiation;response to odorant
- Cellular component
- extracellular region;extracellular space;lysosome;microvillus;external side of plasma membrane;secretory granule;neuron projection;lysosomal lumen;perikaryon;apical part of cell
- Molecular function
- aminopeptidase activity;cysteine-type endopeptidase activity;serine-type endopeptidase activity;protein binding;cysteine-type peptidase activity;kininogen binding;peptide binding;protein-containing complex binding